Disulfide links of the IgGZak anti-ovarian carcinoma antibody, 5G6.4, were site-specifically biotinylated [z 2 biotins/ IgG2a] using a novel crosslinking procedure using the biotin derivatized ETAC (equilibrium transfer alkylation crosslink reagent) la. Complexation of ETAC la biotinylated 5G6.4 on a column of immobilized protein A at high dilution, followed by passage of [i251]streptavidin, washing and pH change leads to elution of a streptavidin-free product with a molecular mass in the 200-300 kDa range. By contrast, direct mixing with [i2Qstreptavidin rapidly gave larger oligomers of $669 and x440-669 kDa molecular mass, respectively. The biodistribution of the 200-300 kDa complex showed significantly diminished liver, kidney and spleen uptake as well as higher blood activity than the W-669 kDa complex. The methodology represent the first application of ETAC chemistry to disulfide-bond directed biotinylation of antibodies and the synthesis of streptavidin antibody conjugates which minimizes their polymerization.
IgG2a] using a novel crosslinking procedure using the biotin derivatized ETAC (equilibrium transfer alkylation crosslink reagent) la. Complexation of ETAC la biotinylated 5G6.4 on a column of immobilized protein A at high dilution, followed by passage of [i251]streptavidin, washing and pH change leads to elution of a streptavidin-free product with a molecular mass in the 200-300 kDa range. By contrast, direct mixing with [i2Qstreptavidin rapidly gave larger oligomers of $669 and x440-669 kDa molecular mass, respectively. The biodistribution of the 200-300 kDa complex showed significantly diminished liver, kidney and spleen uptake as well as higher blood activity than the W-669 kDa complex. The methodology represent the first application of ETAC chemistry to disulfide-bond directed biotinylation of antibodies and the synthesis of streptavidin antibody conjugates which minimizes their polymerization.
Developments in the use of biotinylated antibodies and pre-formed streptavidin biotinylated antibody complexes may have applicability to using such approaches in radioimmunoconjugate delivery (Hnatowich er al., 1987; Paganelli et al., 199Od; Pimm et al., 1988; Sinitsyn et al., 1989) . Successful clinical studies have been reported by at least two groups (Rowlinson et al., 1988; Paganelli et al., 1990a,b,c) . Recently, we reported our findings concerning the potential applications of sulfhydryl site-directed biotinylation as a means of better preserving the immunoreactivity of biotinylated antibodies and thei; corresponding radiolabeled coniugates (de1 Wahl. 1989. 1990 ). These earlier data-grew' from our initial observation that reduced interchain disulfide links of antibodies were readily mono-alkylated with an iodoacetamide derivative of biotin (de1 Rosario and Wahl, 1989) . Following complexation with radio-streptavidin, the oligomeric conjugates retained in vivo immunological activity. However, we and others have recognized that proper control of molecular size and purification remains a key problem in the synthesis cf homogeneous streptavidin-biotinylated-monoclonal IgG complexes for use in radioimmunoimaging (Hnatowich et al., 1987) . Here we describe a simple method for minimizing the molecular size of the conjugate formed upon reaction with streptavidin which allows excess streptavidin to be easily separated from product without HPLC purification.
Biotinylation was accomplished using a novel procedure using the "ETAC" (equilibrium transfer alkylation) crosslink reagent la, prepared in our laboratories (de1 Rosario et al., 1989 (de1 Rosario et al., , 1990 (Fig. 1) . In previous work (de1 Rosario et al., 1989 Liberatore et al., 1990) we have shown that ETAC reagents provide a unique site-specific pathway for attaching a wide range of bioprobes to antibodies, i.e. through insertion and formation of a stable three carbon crosslinked disulfide bridge (de1 Rosario et al., 1990) . In contrast to our earlier papers, ETAC biotinylation proceeds through a bis-alkylation as opposed to a mono-alkylation (as in the reaction of haloacetyl derivatives) of disulfide bonds (de1 Wahl, 1989, 1990) .
We have recently reported the synthesis of the parent compound carboxy ETAC 1 and a biotin derivative, la (de1 Rosario et al., 1989) . Biotinylated ETAC la ( Fig. 1 ) was prepared by carbodiimide-mediated derivatization of carboxy-ETAC 1 with commercially available 5-(((Nbiotinoyl)aminohexanoyl)amino)pentylamine (Molecular Probes) (de1 Rosario et al., 1989) . The anti-ovarian carcinoma IgGZak antibody, 566.4 (Wahl et al., 1986) was chosen for the present study. 566.4 (produced from mouse ascites and purified by protein A chromatography) in 0.1 M sodium phosphate (pH z 7) solution was reduced (37"C, 5 h) with a z 150 molar excess of DTT (Aldrich Chemical Co.). The mixture was treated with a DMSO solution of ETAC la (1: 1 molar ratio with resnect to DlT). vortexed and the emulsion allowed to react for 15-24 h at'j7"C. The reaction mixture was vortexed (15 min) and the clear supernatant desalted over Sephadex G-25 using 0.1 M sodium phosphate buffer @H ~7).
Site-specific crosslinking and biotinylation of interchain disultide links of 5G6.4 was confirmed by reducing SDS-PAGE analysis (Pharmacia Phast System) of the crosslinked products. Since the new -S-{biotinoyl-ETAC}-Schemical bonds were stable even at 100°C and not cleaved by reducing thiols, the crosslinked species appeared as new bands of xH,L,, H,L, H, and HL mass units in addition to uncrosslinked heavy (H) and light (L) chains on electrophoresis. These observations were identical to our previous findings (de1 Rosario et al., 1989 Laemmli, 1970; Liberatore et al., 1990) . Laser densitometric measurement (Pharmacia Ultrascanner) of the Coomassie blue content on each band allowed calculation of an average of ~2 interchain H-H and H-L disulfide attached biotins per biotinylated 566.4 molecule (de1 Rosario et al., 1989, 1990) . As expected the extended "spacer arm" of the new biotin derivative la allowed facile complexation with streptavidin as has been observed with derivatives of N-hydroxysuccinimide esters of biotin (Hnatowich et al., 1987). Reaction of biotinylated 5G6.4 (MW x 150,000) with ['251]streptavidin (MW r 60,000) in approximately equimolar ratios led to formation of complex oligomeric mixtures covering the z 400,000 to B 669,000 molecular mass region. The molecular weights of these conjugates were estimated from calibration plots of known standards using Pharmacia Superose 6 and 12 size-exclusion radio-FPLC as previously described (de1 . Figure 2 (a) shows a representative product profile. With excess biotinylated 566.4, the predominant species was mass 9669 kDa (species A), whereas ~2 or more molar equivalents of streptavidin per mole of biotinylated 566.4 favored species in the lower 400-669 kDa mass range (Species B). *Author for correspondence. Retention of immunoreactivity of the biotinylated and streptavidin-biotinylated 566.4 pre-formed complexes was verified by direct cell binding assays of the radiolabeled complex using human 77 IP3 target cells (de1 . Direct binding of biotinylated 506.4 was indicated by specific binding (60%) of ['251]streptavidin on target cells pre-incubated with the biotinylated 566.4 conjugate. Preformed oligomeric species A ( %-669 kDa) or-B (x400-> 669 kDa) IFig. 2(a)l both exhibited comnarable or better (60-8O%j specilfic binding than ['ZsI]5G6.4 @O-65%) labeled via the iodogen method (at substantial antigen excess). Flow cytometry results using fluorescent streptavidin were identical with those previously reported for the iodoacetyl-biotin conjugate of 566.4 (de1 Wahl, 1989, 1990) . Species A [ Fig. 2(b) ] showed excellent stability in serum (5 days) as assessed by radio-FPLC. Similarly, complex formation was observed when ETAC la biotinylated 566.4 was allowed to mix with radiolabeled streptavidin in serum (Z 1 fig biotinylated  5G6 .4/mL serum) instead of buffer. The preservation of immunoreactivity and stability data are consistent with the hypothesis that ETAC conjugation occur at sites distant from the antigen binding sites and leads to relatively stable biotin ETAC la crosslinks in 566.4. However, a preliminary biodistribution study (mice, n = 3/group) of product complex enriched in species A (B669 kDa) showed large liver (0.263* f 0.016) and spleen (0.539 + 0.134) uptake with very little blood (0.006 + 0.001) pool activity by 48 h in comparison to a 150 kDa radiolabeled non-specific IgG2a antibody (UPC-IO) [liver: 0.055 f 0.006; spleen: 0.167 k 0.026; blood: 0.111 + 0.066, P $0.0005, P C 0.025, P 6 0.10, respectively.*] The above results closely parallel our previous studies concerning the effect of added antimouse antibody on the in vivo behavior of circulating intact radiolabeled UPC-10 and 5G6.4 (Wahl and Fisher, 1987) and implied that large complex size would present a substantial problem in targeting these antibody conjugates to tumors.
*All values are in % kg ID/g (f SEM).
To minimize formation of very large inter-antibody streptavidin oligomers (and their undesired non-target uptake in the liver and spleen), an alternative approach was devised using a protein affinity matrix. The strategy begins by first "anchoring" the same lot of biotinylated 566.4 on protein A (via its Fc portion) at pH 8-9 (Ey et al., 1978) . ['2sI]Radiostreptavidin was passed through the column briefly at high dilution to allow contact with the protein A-bound IgG. Unbound ['251]streptavidin was then washed away and the 5G6.Cbiotinylated streptavidin conjugate was saturated by passing a saturated buffer solution of biotin through the column to block available biotin binding sites on the streptavidin while still being bound to protein A. The product complex was conveniently eluted from off the column by washing at pH 5.
A representative procedure is as follows. The above ETAC la-biotinylated 5G6.4 was thoroughly mixed with immobilized Protein A (Repligenm, ~200-300 pg IgGZa/ 5 mL gel) suspended in 0.1 M sodium phosphate buffer (pH zz 8-9). The slurry was poured into a column.
['251]Streptavidin (30-40 @i/pg, 100-300 PCi) was allowed to run through the column once. The column was washed several times with a saturated solution of biotin in 0.1 M @H x 8-9) sodium phosphate buffer until the eluent showed no change in background activity. Product complex was then eluted with 0.1 M citrate buffer at pH 5 (x 80 pCi) and examined for free streptavidin by size-exclusion radio-FPLC [Pharmacia Superose 6, Fig. 2(c) ] analysis.
Products of significantly lower molecular weight (~200,000-300,000) with radio-FPLC profiles such as C [ Fig. 2(c) ] were eluted at pH 5. The shoulder of peak C (higher molecular mass) in Fig. 2(c) was evident even when the radio-streptavidin used was partially blocked with <4 equivalents of biotin prior to contact with the immobilized biotinvlated IaG. The biodistribution of suecies C was then compared with species B in rats (n = 3) and is summarized in Fig. 3 . The biodistribution (rats, n = 3/group, t = 48 h) of species C showed significantly diminished liver, kidney and spleen uptake as well as higher blood activity than the 440-669 kDa complex {liver ~2.4 [ratio of 440-669 kDa/ 200-300 kDa activity], P C 0.025; kidney s 2.7, P < 0.005; reagent. Bioconj. Chem. 1, 36. complex and (d) illustrates a practical approach for Paganelli G., Magnani P., Ross&i C., Zito F., Belloni C., avoiding high molecular weight oligomers. A limitation of Pasini A., Sassi I., Sanvito F., Siccardi A. G. and Fazio the technique is that it may not be directly applicable to F. (1990a) Tumor targeting in patients with ovarin cancer pre-targeting strategies if all streptavidin sites are preusing biotinylated monoclonal antibodies and radioactive streptavidin. J. Nucl. Med. 31, 735. blocked by biotin. This can be addressed by using lesser quantities of biotin to allow only partial blocking (Green, 1975) . The chemistry of the new biotin derivative, ETAC la further widens the scope and utility of immunologic applications of the biotin-streptavidin couple. Furthermore, the immobilization strategy described herein may find similar applicability in the synthesis of other antibody conjugates where polymer formation is undesirable (Alam et al., 1989 
